TGFB1 and myeloid neoplasm: With respect to serine protease and cathepsins, the upregulation of cathepsin B expression has been reported in myeloid tumor cell lines following TGF-β1 treatment, which identified a link between TGF-β1 signaling and the degradation of ECM components [56].